| 标题 |
Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03 |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:C. Saura; J. Cortés; S. Modi; S.-B. Kim; E. Hamilton; et al 出版日期:2025 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |